Men with type 2 diabetes are at increased risk for death from prostate cancer (PCa) or from any cause, Canadian researchers reported online ahead of print in Cancer Causes & Control.
A team led by Laurent Azoulay, MD, of McGill University in Montreal, studied 11,920 men newly diagnosed with non-metastatic PCa. The cohort included 1,132 men (9.5%) with pre-existing type 2 diabetes. A total of 3,605 deaths, including 1,792 from PCa, occurred during a mean 4.7 years of follow-up. Compared with non-diabetics, men with type 2 diabetes had a 23% increased risk of PCa mortality and 25% increased risk of all-cause mortality, after adjusting for potential confounders, including smoking, excessive alcohol use, comorbidities, and PCa-related variables.
The findings “may signal an association between hyperinsulinemia or other diabetes-associated metabolic derangements and cancer aggressivity,” the authors concluded.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.